Basic Information (Switzerland) Elecon Asia SA (hereinafter referred to as “Elecon”) is a powerful intelligent three-d...
Digital Copyright Ten Major Typical Cases 1.Short Video Copyright Case: Whether a Short Video is Original Has Nothing to...
December 7, 2023 - News of a patent infringement ruling against Apple Watches a few weeks ago caused a flurry of investo...
we sent a Japanese lawyer to the Tokyo District Court in order to get access to the case file of what is the highest-profile patent litigation in the history of the video games industry (April 18
argued there was a risk of imminent infringement of its patent EP 1 830 843 B1, which protects the use of nintedanib or nintedanib esylate, from 12 December 2024. The pharma company also owns the related
The settlement had been hinted at in recent days after signs emerged in the US and at the UPC that hearings were no longer taking place. JUVE Patent learned from lawyers involved in the case that the
and demanded a PI, it filed an action for infringement of EP 533, EP 986, EP 066 and GB patent 2 510 725 at the UK High Court (case ID: HP-2025-000037). Guardant is seeking a permanent injunction
streaming service, which considers DivX's patents invalid. Now the dispute moves to the UPC. In September, the German Federal Court of Justice dismissed DivX’s appeal against the Federal Patent Court’s
Chinese access control leader Hongmen Advanced Technology Corporation is now involved in a new patent dispute with its industry rival Shenzhen Jieshun Science and Technology Industry Co., Ltd.
). But almost three years ago, patent pool administrator Vectis IP launched an Opus pool to collect royalties on behalf of companies not bound by a royalty-free licensing pledge (pool website). Its key
infringes a patent held by Fresenius Kabi, thus overturning a first-instance decision. Fresenius Kabi alleges that Biogen’s Imraldi has infringed its EP 3 145 488 B1 for a ‘liquid pharmaceutical
Chinese cloud-computing giant Inspur has withdrawn its patent invalidity challenges against Hewlett Packard Enterprise (HPE), signaling a potential shift in the ongoing cross-border intellectual
include in the application,” writes Arnold. But, while “there is no evidence before this Court as to whether the same was true of dapagliflozin and the application for the patent”, Arnold emphasises
CHINA intellectual PROPERTY LAWYERS NETWORK
+86-13910160652
ciplawyers@163.com
